• Three blood tests detected prion infection in sheep blood samples up to 26 months before the onset of clinical signs, with 100% specificity.

  • The tests are applicable to human variant Creutzfeldt-Jakob brain samples and may be adaptable for prion detection in human blood.

Abstract

Variant Creutzfeldt-Jakob disease (vCJD) is a devastating disease caused by transmission of bovine spongiform encephalopathy to humans. Although vCJD cases are now rare, evidence from appendix surveys suggests that a small proportion of the United Kingdom population may be infected without showing signs of disease. These “silent” carriers could present a risk of iatrogenic vCJD transmission through medical procedures or blood/organ donation, and currently there are no validated tests to identify infected asymptomatic individuals using easily accessible samples. To address this issue, we evaluated the performance of 3 blood-based assays in a blinded study, using longitudinal sample series from a well-established large animal model of vCJD. The assays rely on amplification of misfolded prion protein (PrPSc; a marker of prion infection) and include real-time quaking-induced conversion (RT-QuIC), and 2 versions of protein misfolding cyclic amplification (PMCA). Although diagnostic sensitivity was higher for both PMCA assays (100%) than RT-QuIC (61%), all 3 assays detected prion infection in blood samples collected 26 months before the onset of clinical signs and gave no false-positive results. Parallel estimation of blood prion infectivity titers in a sensitive transgenic mouse line showed positive correlation of infectivity with PrPSc detection by the assays, suggesting that they are suitable for detection of asymptomatic vCJD infection in the human population. This study represents, to our knowledge, the largest comparison to date of preclinical prion detection in blood samples from a relevant animal model. The outcomes will guide efforts to improve early detection of prion disease and reduce infection risks in humans.

1.
Prusiner
SB
.
Prions
.
Proc Natl Acad Sci U S A
.
1998
;
95
(
23
):
13363
-
13383
.
2.
Collinge
J
.
Prion diseases of humans and animals: their causes and molecular basis
.
Annu Rev Neurosci
.
2001
;
24
:
519
-
550
.
3.
Cohen
FE
,
Prusiner
SB
.
Pathologic conformations of prion proteins
.
Annu Rev Biochem
.
1998
;
67
:
793
-
819
.
4.
Ironside
JW
.
Pathology of variant Creutzfeldt-Jakob disease
.
Arch Virol Suppl
.
2000
(
16
):
143
-
151
.
5.
van Keulen
LJM
,
Vromans
MEW
,
van Zijderveld
FG
.
Early and late pathogenesis of natural scrapie infection in sheep
.
APMIS
.
2002
;
110
(
1
):
23
-
32
.
6.
Head
MW
,
Ritchie
D
,
Smith
N
, et al
.
Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study
.
Am J Pathol
.
2004
;
164
(
1
):
143
-
153
.
7.
Ladogana
A
,
Puopolo
M
,
Croes
EA
, et al
.
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada
.
Neurology
.
2005
;
64
(
9
):
1586
-
1591
.
8.
Will
RG
,
Ironside
JW
,
Zeidler
M
, et al
.
A new variant of Creutzfeldt-Jakob disease in the UK
.
Lancet
.
1996
;
347
(
9006
):
921
-
925
.
9.
Collinge
J
,
Sidle
KCL
,
Meads
J
,
Ironside
J
,
Hill
AF
.
Molecular analysis of prion strain variation and the aetiology of “new variant” CJD
.
Nature
.
1996
;
383
(
6602
):
685
-
690
.
10.
Hill
AF
,
Desbruslais
M
,
Joiner
S
, et al
.
The same prion strain causes vCJD and BSE
.
Nature
.
1997
;
389
(
6650
):
448
-
526
.
11.
Bruce
ME
,
Will
RG
,
Ironside
JW
, et al
.
Transmissions to mice indicate that “new variant” CJD is caused by the BSE agent
.
Nature
.
1997
;
389
(
6650
):
498
-
501
.
12.
Ward
HJT
,
Everington
D
,
Cousens
SN
, et al
.
Risk factors for variant Creutzfeldt-Jakob disease: a case-control study
.
Ann Neurol
.
2006
;
59
(
1
):
111
-
120
.
13.
Urwin
PJM
,
Mackenzie
JM
,
Llewelyn
CA
,
Will
RG
,
Hewitt
PE
.
Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK transfusion medicine epidemiology review study
.
Vox Sang
.
2016
;
110
(
4
):
310
-
316
.
14.
Hewitt
PE
,
Llewelyn
CA
,
Mackenzie
J
,
Will
RG
.
Creutzfeldt-Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study
.
Vox Sang
.
2006
;
91
(
3
):
221
-
230
.
15.
Llewelyn
CA
,
Hewitt
PE
,
Knight
RSG
, et al
.
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion
.
Lancet
.
2004
;
363
(
9407
):
417
-
421
.
16.
Peden
AH
,
Head
MW
,
Ritchie
DL
,
Bell
JE
,
Ironside
JW
.
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
.
Lancet
.
2004
;
364
(
9433
):
527
-
529
.
17.
Gregori
L
,
Yang
H
,
Anderson
S
.
Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood
.
Transfusion (Paris)
.
2011
;
51
(
12
):
2596
-
2602
.
18.
Douet
JY
,
Zafar
S
,
Perret-Liaudet
A
, et al
.
Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease
.
Emerg Infect Dis
.
2014
;
20
(
1
):
114
-
117
.
19.
Elder
AM
,
Henderson
DM
,
Nalls
A V
, et al
.
In vitro detection of prionemia in TSE-infected cervids and hamsters
.
PLoS One
.
2013
;
8
(
11
):
e80203
.
20.
Elder
AM
,
Henderson
DM
,
Nalls
A V
, et al
.
Immediate and ongoing detection of prions in the blood of hamsters and deer following oral, nasal, or blood inoculations
.
J Virol
.
2015
;
89
(
14
):
7421
-
7424
.
21.
McNulty
EE
,
Nalls
AV
,
Xun
R
,
Denkers
ND
,
Hoover
EA
,
Mathiason
CK
.
In vitro detection of haematogenous prions in white-tailed deer orally dosed with low concentrations of chronic wasting disease
.
J Gen Virol
.
2020
;
101
(
3
):
347
-
361
.
22.
Edgeworth
JA
,
Farmer
M
,
Sicilia
A
, et al
.
Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay
.
Lancet
.
2011
;
377
(
9764
):
487
-
493
.
23.
Denkers
ND
,
Henderson
DM
,
Mathiason
CK
,
Hoover
EA
.
Enhanced prion detection in biological samples by magnetic particle extraction and real-time quaking-induced conversion
.
J Gen Virol
.
2016
;
97
(
8
):
2023
-
2029
.
24.
Bougard
D
,
Brandel
JP
,
Bélondrade
M
, et al
.
Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease
.
Sci Transl Med
.
2016
;
8
(
370
):
370ra182
.
25.
Concha-Marambio
L
,
Chacon
MA
,
Soto
C
.
Preclinical detection of prions in blood of nonhuman primates infected with variant Creutzfeldt-Jakob disease
.
Emerg Infect Dis
.
2020
;
26
(
1
):
34
-
43
.
26.
Orrú
CD
,
Wilham
JM
,
Raymond
LD
, et al
.
Prion disease blood test using immunoprecipitation and improved quaking-induced conversion
.
mBio
.
2011
;
2
(
3
):
e00078
-
ee1111
.
27.
Vascellari
S
,
Orrù
CD
,
Hughson
AG
, et al
.
Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC
.
PLoS One
.
2012
;
7
(
11
):
e48969
.
28.
Saborio
GP
,
Permanne
B
,
Soto
C
.
Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding
.
Nature
.
2001
;
411
(
6839
):
810
-
813
.
29.
Soto
C
,
Saborio
GP
,
Anderes
L
.
Cyclic amplification of protein misfolding: application to prion-related disorders and beyond
.
Trends Neurosci
.
2002
;
25
(
8
):
390
-
394
.
30.
Wilham
JM
,
Orrú
CD
,
Bessen
RA
, et al
.
Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays
.
PLoS Pathog
.
2010
;
6
(
12
):
e1001217
.
31.
Concha-Marambio
L
,
Pritzkow
S
,
Moda
F
, et al
.
Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease
.
Sci Transl Med
.
2016
;
8
(
370
):
370ra183
.
32.
Green
AJE
.
RT-QuIC: a new test for sporadic CJD
.
Pract Neurol
.
2019
;
19
(
1
):
49
-
55
.
33.
Cheng
YC
,
Hannaoui
S
,
John
TR
,
Dudas
S
,
Czub
S
,
Gilch
S
.
Real-time quaking-induced conversion assay for detection of CWD prions in fecal material
.
J Vis Exp
.
2017
;
127
:
56373
.
34.
Tennant
JM
,
Li
M
,
Henderson
DM
, et al
.
Shedding and stability of CWD prion seeding activity in cervid feces
.
PLoS One
.
2020
;
15
(
3
):
e0227094
.
35.
Thomas
CM
,
Salamat
MK
,
de Wolf
C
, et al
.
Development of a sensitive real-time quaking-induced conversion (RT-QuIC) assay for application in prion-infected blood
.
PLoS One
.
2023
;
18
(
11
):
e0293845
.
36.
Salamat
MKF
,
Blanco
ARA
,
McCutcheon
S
, et al
.
Preclinical transmission of prions by blood transfusion is influenced by donor genotype and route of infection
.
PLoS Pathog
.
2021
;
17
(
2
):
e1009276
.
37.
Moudjou
M
,
Sibille
P
,
Fichet
G
, et al
.
Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification
.
mBio
.
2013
;
5
(
1
):
e00829
.
38.
Lacroux
C
,
Comoy
E
,
Moudjou
M
, et al
.
Preclinical detection of variant CJD and BSE prions in blood
.
PLoS Pathog
.
2014
;
10
(
6
):
e1004202
.
39.
Segarra
C
,
Bougard
D
,
Moudjou
M
,
Laude
H
,
Béringue
V
,
Coste
J
.
Plasminogen-based capture combined with amplification technology for the detection of PrPTSE in the pre-clinical phase of infection
.
PLoS One
.
2013
;
8
(
7
):
e69632
.
40.
Houston
F
,
McCutcheon
S
,
Goldmann
W
, et al
.
Prion diseases are efficiently transmitted by blood transfusion in sheep
.
Blood
.
2008
;
112
(
12
):
4739
-
4745
.
41.
McCutcheon
S
,
Alejo Blanco
AR
,
Houston
EF
, et al
.
All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD
.
PLoS One
.
2011
;
6
(
8
):
e23169
.
42.
Castilla
J
,
Gutiérrez Adán
A
,
Brun
A
, et al
.
Early detection of PrPres in BSE-infected bovine PrP transgenic mice
.
Arch Virol
.
2003
;
148
(
4
):
677
-
691
.
43.
Padilla
D
,
Béringue
V
,
Espinosa
JC
, et al
.
Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice
.
PLoS Pathog
.
2011
;
7
(
3
):
e1001319
.
44.
Arnold
ME
,
Hawkins
SAC
,
Green
R
,
Dexter
I
,
Wells
GAH
.
Pathogenesis of experimental bovine spongiform encephalopathy (BSE): estimation of tissue infectivity according to incubation period
.
Vet Res
.
2009
;
40
(
1
):
8
.
45.
Kupfer
L
,
Eiden
M
,
Buschmann
A
,
Groschup
MH
.
Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras
.
Biochim Biophys Acta
.
2007
;
1772
(
6
):
704
-
713
.
46.
Salamat
MK
,
Dron
M
,
Chapuis
J
,
Langevin
C
,
Laude
H
.
Prion propagation in cells expressing PrP glycosylation mutants
.
J Virol
.
2011
;
85
(
7
):
3077
-
3085
.
47.
Béringue
V
,
Le Dur
A
,
Tixador
P
, et al
.
Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD
.
PLoS One
.
2008
;
3
(
1
):
e1419
.
48.
Hajian-Tilaki
K
.
Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation
.
Caspian J Intern Med
.
2013
;
4
(
2
):
627
-
635
.
49.
Sawyer
EB
,
Edgeworth
JA
,
Thomas
C
,
Collinge
J
,
Jackson
GS
.
Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion disease
.
Sci Rep
.
2015
;
5
:
17742
.
50.
Yakovleva
O
,
Bett
C
,
Pilant
T
,
Asher
DM
,
Gregori
L
.
Abnormal prion protein, infectivity and neurofilament light-chain in blood of macaques with experimental variant Creutzfeldt-Jakob disease
.
J Gen Virol
.
2022
;
103
(
7
):
001764
.
51.
Kramm
C
,
Pritzkow
S
,
Lyon
A
,
Nichols
T
,
Morales
R
,
Soto
C
.
Detection of prions in blood of cervids at the asymptomatic stage of chronic wasting disease
.
Sci Rep
.
2017
;
7
(
1
):
17241
.
52.
Douet
JY
,
Lacroux
C
,
Aron
N
, et al
.
Distribution and quantitative estimates of variant Creutzfeldt-Jakob disease prions in tissues of clinical and asymptomatic patients
.
Emerg Infect Dis
.
2017
;
23
(
6
):
946
-
956
.
53.
Salamat
MKF
,
Stewart
P
,
Brown
H
, et al
.
Subclinical infection occurs frequently following low dose exposure to prions by blood transfusion
.
Sci Rep
.
2022
;
12
(
1
):
10923
.
54.
Douet
JY
,
Huor
A
,
Cassard
H
, et al
.
Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
.
Acta Neuropathol
.
2021
;
141
(
3
):
383
-
397
.
You do not currently have access to this content.
Sign in via your Institution